Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0001047469-99-002575
Filing Date
1999-01-29
Accepted
1999-01-29 00:00:00
Documents
11
Period of Report
1998-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405/A 10-K405/A 112325
2 EXHIBIT 10.15 EX-10.15 19223
3 EXHIBIT 10.16 EX-10.16 19074
4 EXHIBIT 10.17 EX-10.17 12700
5 EXHIBIT 10.23 EX-10.23 18619
6 EXHIBIT 10.24 EX-10.24 3213
7 EXHIBIT 11.1 EX-11.1 2208
8 EXHIBIT 13.1 EX-13.1 144932
9 EXHIBIT 23.1 EX-23.1 1149
10 EXHIBIT 27 EX-27 2295
11 EXHIBIT 99.1 EX-99.1 1903
  Complete submission text file 0001047469-99-002575.txt   340019
Mailing Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121
Business Address 3099 SCIENCE PK RD STE 150 SAN DIEGO CA 92121 6194534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405/A | Act: NE | File No.: 001-14430 | Film No.: 99515919
SIC: 2833 Medicinal Chemicals & Botanical Products